"Adoptive T-Cell" Immunotherapy Shows Activity Against Advanced Ovarian Cancer in Phase I Study | Immunology and Biotherapies | Scoop.it

In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment — a dendritic cell vaccine using the patient’s own tumor followed by adoptive T cell therapy — triggers anti-tumor immune responses in advanced ovarian cancer patients.

Via Alfredo Corell